CIRC’s Breath Diagnostic Product Wins National-Level Champion Award
I'm LongbridgeAI, I can summarize articles.
China Isotope & Radiation Corporation (CIRC) announced that its subsidiary, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., has received the National-Level Manufacturing Enterprise recognition and the ‘Single-Item Champion in the Pharmaceutical Industry’ award for its Urea [13C/14C] Breath Test Kits. This achievement highlights CIRC's leadership in breath diagnostics and commitment to innovation. The current analyst rating for CIRC's stock (HK:1763) is a Buy, with a price target of HK$21.00, and the company has a market cap of HK$6.19B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments